A woman from Liverpool, Chloe, who nearly died after self-administering an unregulated weight loss drug, warns others about the dangers of illegal "skinny jabs," highlighting the risks of black market injections that can contain harmful substances and have led to hospitalizations and even fatalities. #WeightLoss #HealthRisks #SkinnyJabs #GB #CN #KR
The article discusses the rising dangers associated with the use of "skinny jabs" for weight loss in the UK, highlighting cases of adverse health effects, including a death connected to such treatments, and the challenges patients face in accessing these medications safely through the NHS due to strict eligibility criteria and high costs. #WeightLoss #HealthRisks #ObesityTreatment #GB
Chloe, a woman from Liverpool, warns against the dangers of unregulated weight loss drugs after suffering severe health complications from a black market injection, highlighting the risks of illegal sales and the need for stricter enforcement against such practices. #WeightLoss #HealthRisks #EatingDisorders #GB #CN #KR
The article highlights the alarming trend of individuals in the UK suffering severe health issues or even death after using illegal weight loss injections, known as "skinny jabs," due to strict NHS access and affordability issues, prompting concerns from medical experts about the risks associated with counterfeit and shared medications. #WeightLoss #HealthRisks #ObesityTreatment #GB
A woman from Liverpool, Chloe, who suffered severe health complications after self-injecting an unregulated weight loss drug purchased from a friend, is warning others about the dangers of black market "skinny jabs," emphasizing the need for stricter enforcement against illegal sellers as these products can contain harmful substances. #WeightLoss #HealthRisks #EatingDisorders #UK #CN #KR
Concerns are rising in the UK as the trend of using "skinny jabs" for weight loss has led to hospitalizations, including a recent death, due to unsafe practices and the inaccessibility of prescribed medications like Mounjaro and Wegovy, which are not available to many patients despite qualifying under NHS guidelines. #WeightLoss #HealthRisks #ObesityTreatment #GB
A woman from Liverpool, who suffered severe health complications after injecting herself with an unregulated weight loss drug sourced from a "friend of a friend," is cautioning others about the dangers of illegal "skinny jabs," which can contain harmful substances and are often sold without proper medical supervision. #WeightLoss #HealthRisks #UnregulatedDrugs #GB #CN #KR
A growing number of people in the UK are being hospitalized due to unsafe "skinny jabs," including a tragic case where a woman died after receiving a weight loss injection, prompting experts to warn against the dangers of illegally obtained drugs and the strict NHS criteria that limit access to legitimate treatments for obesity. #WeightLoss #HealthRisks #ObesityTreatment #GB
A woman from Liverpool, Chloe, warns others about the dangers of unregulated weight loss injections after suffering severe health complications from a black market "skinny jab," highlighting the risks associated with illegal sellers and the urgent need for stricter regulations. #WeightLoss #HealthRisks #IllegalDrugs #GB
A woman from Liverpool, who nearly died after injecting herself with a black market weight loss drug, is warning others about the dangers of unregulated jabs, highlighting the risks of illegal sellers and the potentially harmful substances they contain. #WeightLoss #HealthRisks #UnregulatedMarket #GB
A new daily pill, orforglipron, may help individuals who stop using injectable weight-loss medications maintain their weight loss, as research indicates that patients using the pill were able to keep over 70% of the weight they lost, while those on a placebo maintained only 38-50%, with the study highlighting orforglipron's potential benefits in managing obesity as a chronic disease. #WeightLoss #ObesityTreatment #HealthInnovation #US #GB
A new daily pill called orforglipron may help individuals who stop using injectable weight loss medications maintain their weight loss, as a study shows that those taking the pill retained over 70% of their lost weight after a year, compared to 38-50% for the placebo group, with further research needed to determine the long-term effects of the treatment. #WeightLoss #ObesityTreatment #HealthResearch #US #GB
A new daily pill, orforglipron, has shown promise in helping individuals maintain weight loss after stopping injectable weight loss medications, with study participants who took the pill retaining over 70% of their weight loss, while those on a placebo maintained only 38-50%, suggesting a potential shift in obesity treatment methods. #WeightLoss #ObesityTreatment #HealthResearch #US #GB
A new pill called orforglipron may help prevent weight regain in individuals who have stopped using weight loss injections, with research indicating that those taking it daily for a year maintained over 70% of their initial weight loss, and its potential for broader availability following approval in the U.S. and possibly the U.K. soon. #WeightLoss #ObesityTreatment #HealthResearch #US #GB
A new daily pill, orforglipron, may help individuals maintain weight loss after discontinuing injectable weight loss medications, according to a study published in Nature Medicine, which found that participants taking the pill preserved over 70% of their weight loss compared to 38-50% in the placebo group, suggesting that oral medication could offer a more appealing alternative to injections for long-term obesity management. #WeightLoss #ObesityTreatment #HealthResearch #US #UK
A new pill named orforglipron may help individuals who have stopped using weight-loss injections maintain their weight loss, as a study showed that participants taking the pill daily for a year effectively prevented weight regain, while also improving health markers related to obesity, though further research is needed to determine the long-term effects and optimal duration of treatment. #WeightLoss #ObesityTreatment #HealthResearch #US #GB
A new daily pill called orforglipron may help individuals maintain weight loss after stopping injectable weight loss medications, with a study showing that participants taking orforglipron retained over 70% of their previous weight loss compared to a placebo group, although further research is needed to determine the long-term effects of the treatment. #WeightLoss #ObesityTreatment #HealthBenefits #US #GB
A new pill called orforglipron may help prevent weight regain in individuals who stop using weight-loss injections, demonstrating promising results in a study where participants who took the pill daily maintained over 70% of their initial weight loss after discontinuing GLP-1 injections, highlighting the need for further research on its long-term efficacy and treatment duration. #WeightLoss #ObesityResearch #Medication #US #GB
A new daily pill, orforglipron, could aid individuals in maintaining weight loss after discontinuing injectable weight-loss medications, with a study showing participants who took the pill daily during a year retained over 70% of their previous weight loss compared to 38-50% in those on a placebo, while also potentially mitigating long-term obesity-related health risks. #WeightLoss #ObesityTreatment #ChronicDisease #US #GB
A new pill called orforglipron may help prevent weight regain in individuals who stop using weight loss injections, according to research published in Nature Medicine, which found that patients taking the pill daily for a year maintained over 70% of their weight loss after discontinuing GLP-1 injections; however, experts emphasize the need for further studies on the duration of treatment and its long-lasting effects on obesity management. #WeightLoss #ObesityTreatment #PharmaceuticalResearch #US #UK